News | September 20, 2023
Jupiter Life Line Hospitals lists at 32.38% premium
The market capitalization of the company stood at Rs. 7,000 crore +
The market capitalization of the company stood at Rs. 7,000 crore +
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Sets price band at ?695 to ?735 per Equity Share
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated
